Mergers and Acquisitions September 2025
About the course
This subject examines the history of, and reasons for, merger & acquisition activity providing a rationale for the study of the following elements of the process of merger:
The search for and evaluation of strategic targets
The legal and operational due diligence processes
Offensive and defensive M&A tactics by both acquirers and targets
Valuation and financing of acquisitions and the importance of post-deal integration
DATES:
8-12th September 2025
DELIVERY:
This course will be a residential module
FEES
AUD $6,500
Please note fees include tuition, materials, accommodation and meals.
APPLICATIONS:
Unless you have previously enrolled, you will need to enroll with the Melbourne Business School to complete the module. To do this, download and complete an Application Form and return to FEAL with the supporting documentation. Please note new enrolments can take 2-3 weeks for processing.
If you have previously enrolled with the Melbourne Business School - either for the FEAL/MBS Masters Program or any other course - you do not need to complete the Application Forum again. Please email Katrina Bacon, CEO, FEAL katrina.bacon@feal.asn.au to advise your intention to complete this module.
TAUGHT BY:
David Trende, Principal Fellow, Melbourne Business School
ABOUT THE LECTURER:
David Trende is a Principal Fellow of the school and has taught continuously at MBS since 1986. After graduation David tutored and lectured in the Department of Accounting & Finance at Monash University for sixteen years to both undergraduates and students in the Monash MBA program. In 1986 he joined MBS as an adjunct and continues to teach across almost all the award programs offered by the school. This includes the regular MBA, Executive MBA and Senior Executive MBA.
He has also taught on many executive education courses for the school as well as privately conducting many courses for some of Australia’s leading corporates.
David is still active as a founding partner of a boutique corporate advisory firm, currently active in commercializing medical devices. He and his fellow founding partner formed, acquired, owned and managed many small and medium businesses over the years, including a number housed in small listed companies.
